Ebronucimab
Ebronucimab (AK102) is an IgG1-λ2 antibody targeting PCSK9 and is primarily expressed by CHO DG44 (Chinese Hamster Ovary) cells[1].
Product Specifications
CAS Number
[2304800-90-4]
Product Name Alternative
AK102
UNSPSC
12352203
Target
PCSK9
Type
Inhibitory Antibodies
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/ebronucimab.html
Purity
99.9
Solubility
10 mM in DMSO
Smiles
[Ebronucimab]
Molecular Weight
(144.74 kDa)
References & Citations
[1]Ebronucimab. IMGT.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx431233 200 µL
Epidermal Growth Factor Receptor Pathway Substrate 8 (EPS8) Antibody
Ask
View Details 
46580121 3x 1.0µg DNA
TFPI2 CRISPRa sgRNA lentivector (set of three targets)(Human)
Ask
View Details TA505702BM 100 µL
MEK1 (MAP2K1) Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI2D4]
Ask
View Details